Business Details
14 Years
experience
Accelerating Clinical Research Innovation Through Collaboration
Trans Celerate Bio Pharma is a non-profit catalyst for change in clinical research, dedicated to accelerating the development of life-saving medicines through industry-wide collaboration. Founded in 2012, we unite biopharmaceutical companies, health authorities, CROs, and patient communities to address common R&D challenges. Our patient-centered approach focuses on redesigning clinical trials to align with real-world patient experiences, making participation more accessible and meaningful. With over 570 tools and solutions developed, we drive innovation in trial design, data sharing, and safety management. Our pragmatic solutions simplify clinical research processes while maintaining rigorous quality standards. We operate through a collaborative model involving 20 leading member companies and over 1,000 global stakeholders.Our strategic priorities include transforming connectivity in healthcare ecosystems, advancing information sharing, and modernizing clinical trial design. We maintain transparent partnerships with regulatory bodies, investigator sites, and academic institutions to ensure our solutions meet global needs. Our team combines decades of pharmaceutical R&D expertise with forward-thinking innovation to reshape clinical research. We measure success through the tangible impact our solutions create across the biopharma industry and patient communities. Through continuous engagement with diverse stakeholders, we foster a dynamic ecosystem that evolves with emerging scientific and technological advancements.
Services
Clinical Trial Solutions
Patient Engagement Tools
Data Sharing Frameworks
Safety Management Systems
Regulatory Compliance Resources
Details
- Year established: 2012
Highlights and features
- We are a non-profit catalyst with 10+ years of experience transforming clinical research
- Our portfolio includes 570+ industry-validated tools and solutions
- We implement patient-centered approaches that improve trial accessibility and engagement
- We maintain strategic partnerships with global health authorities and CROs
- Our collaborative model has engaged 700+ stakeholders across biopharma R&D
What people say
Transformative impact
Efficient solutions
Patient-centric approach
Global collaboration
Innovative frameworks
Services
Clinical Trial Solutions
We develop standardized frameworks to modernize clinical trial conduct and improve research efficiency. Our solutions address protocol design, site qualification, and data collection challenges. These tools help reduce administrative burdens while maintaining scientific rigor and patient safety.
Patient Engagement Tools
Our patient-focused solutions include advisory boards and experience questionnaires to improve trial participation. We create resources that enhance patient recruitment, retention, and satisfaction through real-world insights. These tools help align clinical research with patient needs and expectations.
Data Sharing Frameworks
We establish protocols for responsible data reuse and interoperability across research platforms. Our frameworks enable secure information sharing between stakeholders while maintaining compliance. These systems support evidence-based decision making throughout drug development.
Safety Management Systems
Our solutions standardize adverse event reporting and pharmacovigilance processes across organizations. We develop tools for rapid signal assessment and quality management implementation. These systems enhance patient safety while streamlining regulatory compliance.
Regulatory Compliance Resources
We create practical tools to help organizations implement evolving regulatory requirements. Our resources include common protocol templates and interpretation guides for global standards. These materials simplify compliance while maintaining scientific integrity.
People
Janice Chang
CEO
As CEO, Janice leads TransCelerate's mission to transform clinical research through industry collaboration. She brings extensive pharmaceutical R&D leadership experience to drive strategic initiatives.
Allison Cuff Shimooka
COO
As COO, Allison oversees operational execution of TransCelerate's collaborative initiatives. She ensures alignment between strategic goals and practical implementation across global stakeholder networks.
Eliav Barr
Chair of the Board
As Chair, Eliav provides strategic guidance to advance TransCelerate's vision. His expertise in clinical development shapes the organization's approach to industry-wide challenges.
Thomas Senderovitz
Vice Chair of the Board
Thomas contributes data science expertise to TransCelerate's initiatives. His leadership helps shape analytical approaches that drive evidence-based solutions for clinical research challenges.
Jennifer Sheller
Corporate Treasurer
Jennifer oversees financial stewardship while leading global clinical trial operations initiatives. Her dual role ensures financial sustainability aligns with operational excellence in research delivery.
Questions
What is TransCelerate's primary mission?
We aim to accelerate clinical research through industry-wide collaboration, developing practical solutions to common R&D challenges.
How does TransCelerate involve patients in research?
We engage patient communities through advisory boards and feedback mechanisms to ensure patient-centered trial design.
What types of solutions do you develop?
We create tools for clinical trial optimization, data sharing, safety management, and regulatory compliance across 50+ therapeutic areas.
How can organizations implement your solutions?
Our 570+ resources are available for public download with implementation guidance through our awareness community.
What is your collaborative model?
We unite 20+ biopharma companies, health authorities, CROs, and patient groups to co-create industry-wide solutions.
How do you measure success?
Through documented implementation experiences showing improved efficiency, patient outcomes, and research quality across global stakeholders.
Videos
